Stock comparison
Bristol-Myers Squibb
Mettler-Toledo International
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
BMY
Bristol-Myers Squibb
Market cap
$116.4B
Sector
Healthcare
MTD
Mettler-Toledo International
Market cap
$26.47B
Sector
Healthcare
Overall winner
Mettler-Toledo International MTD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | BMY | MTD | Winner |
|---|---|---|---|
| Warren Buffett | 50C | 62C | MTD |
| Benjamin Graham | 50C | 38D | BMY |
| Philip Fisher | 39D | 57C | MTD |
| Peter Lynch | 53C | 52C | BMY |
| Joel Greenblatt | 27F | 65B | MTD |
| Charlie Munger | 47D | 65B | MTD |
| Terry Smith | 44D | 64C | MTD |
Side-by-side metrics
| Metric | BMY | MTD |
|---|---|---|
| Market cap | $116.4B | $26.47B |
| P/E (TTM) | 16.0x | 30.5x |
| EV/EBIT | 11.9x | 25.7x |
| ROIC (TTM) | 13.55% | 35.46% |
| Gross margin | 68.75% | 57.52% |
| Net margin | 15.01% | 21.59% |
| Revenue CAGR 5y | 0.96% | 2.01% |
| EPS CAGR 5y | 2.37% | 6.12% |
| Debt / Equity | 2.2x | - |
| Dividend yield | 4.39% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
BMY leads on
- Dividend yield4.39%vs 0.0%+100%
- Market cap$116.4Bvs $26.47B+77%
- EV/EBIT11.9xvs 25.7x+54%
- P/E (TTM)16.0xvs 30.5x+48%
MTD leads on
- Debt / Equity-vs 2.2x+102%
- ROIC (TTM)35.46%vs 13.55%+62%
- EPS CAGR 5y6.12%vs 2.37%+61%
- Revenue CAGR 5y2.01%vs 0.96%+52%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.